High Court sides with generic drug makers in narrow ruling – 06/23/11

The Supreme Court issued a troubling decision that stands as a direct threat to consumer protection within the pharmaceutical industry.  The Court determined that generic drug companies do not share the same level of responsibility as makers of brand-name equivalents, to update their warning labels when significant new risks emerge.  Generic drugs now account for more than 70% of prescriptions filled in the U.S.  The Court’s decision to shield generic drug companies from liability goes against precedent and public policy.

Read more:  http://www.cnn.com/2011/HEALTH/06/23/scotus.generic.drugs/index.html